Sarcena, Martin L.
HRN: 21-40-13 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2023
CEFTAZIDIME 1GM (VIAL)
04/30/2023
05/07/2023
1GRAM
1gram
Q8hrs
CAP-MR
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes